Results 181 to 190 of about 144,583 (352)

Disparities in Growth Hormone Deficiency Screening, Evaluation, Diagnosis, and Treatment Among At‐Risk Childhood Cancer Survivors in the US

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Minoritized childhood cancer survivors (CCS) may encounter barriers to timely late effects surveillance. We aimed to evaluate clinical and demographic differences in the likelihood of, and timing to, growth hormone deficiency (GHD) screening, evaluation, diagnosis, and treatment among at‐risk CCS treated with radiation therapy (RT).
Fulfilled Ighalo   +7 more
wiley   +1 more source

Impact of One-Week Administration of Dihydrotestosterone in Rat Anterior Pituitary Gland. [PDF]

open access: yesInt J Endocrinol, 2022
Kanasaki H   +6 more
europepmc   +1 more source

Investigation of the Mechanism of Cinnamaldehyde in Irritable Bowel Syndrome Based via Network Pharmacology, Molecular Docking, and Animal Experiments

open access: yesPediatric Discovery, EarlyView.
Through network pharmacology and molecular docking, it has been discovered that CA can target MAOB, among other proteins, to exert a therapeutic effect in IBS. In vivo, CA lowered visceral hypersensitivity, anxiety and depression‐like behaviors, and fecal water content, highlighting its therapeutic potential for IBS via anti‐inflammatory pathways ...
Qingyang Yu   +4 more
wiley   +1 more source

Fluctuation of CD9/SOX2-positive cell populations during the turnover of GH- and TSH-producing cells in the adult anterior pituitary gland. [PDF]

open access: yesJ Reprod Dev, 2023
Horiguchi K   +7 more
europepmc   +1 more source

Safety of 12‐Months Administration of Ashwagandha (Withania somnifera) Standardized Root Extract in Healthy Adults: A Prospective, Observational Study

open access: yesPhytotherapy Research, EarlyView.
ABSTRACT Ashwagandha, an adaptogen, is an important herb of Ayurveda used as a Rasayana for its various health benefits. This prospective, multi‐center, observational clinical study evaluates the safety (clinical and laboratory) of a standardized Ashwagandha Root Extract (ARE) on long‐term administration over 12 months. Male and female adults (N = 191)
Jaising Salve   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy